ALPS Medical Breakthroughs ETF SBIO

Full chart Compare
Set alert

Price alert · SBIO

All alert types
55.81 USD +1.44 (+2.65%)

At closeNov 4, 2026, 4:00 PM EST

55.81 0.00 0.00%

After hours · Nov 4, 4:00 PM ET

53.95 Day range 55.93
43.10 52-week range 70.85
YTD
+8.96%
1 year
+27.86%

ALPS Medical Breakthroughs ETF

Issuer
ALPS Funds
Asset class
Equity
Expense ratio
0.50%
Assets under management
$182.22M
NAV
54.40
Holdings
103
Inception
2014-12-30
Top 10 weight
31.52%

Top holdings

  1. ORKA Oruka Therapeutics Inc. 4.43%
  2. CGON CG oncology Inc. 3.82%
  3. MANE VeraDermics Inc. 3.75%
  4. TVTX Travere Therapeutics Inc. 3.13%
  5. DNTH Dianthus Therapeutics Inc. 3.11%
  6. DFTX Definium Therapeutics Inc. 3.02%
  7. EWTX Edgewise Therapeutics Inc. 2.75%
  8. RLAY Relay Therapeutics Inc. 2.57%
  9. XENE Xenon Pharmaceuticals Inc. 2.49%
  10. AMLX Amylyx Pharmaceuticals Inc. 2.46%
  11. ACAD ACADIA Pharmaceuticals Inc. 2.38%
  12. DYN Dyne Therapeutics Inc. 2.26%
  13. TARS Tarsus Pharmaceuticals Inc. 2.14%
  14. IRON Disc Medicine Inc. 2.09%
  15. DNLI Denali Therapeutics Inc. 2.09%
  16. IDYA Ideaya Biosciences Inc. 2.03%
  17. VRDN Viridian Therapeutics Inc. 1.91%
  18. MBX MBX Biosciences Inc. 1.78%
  19. ZLAB Zai Lab Ltd. 1.66%
  20. NAMS Newamsterdam Pharma Co. NV 1.60%
  21. CLDX Celldex Therapeutics Inc. 1.57%
  22. IMNM Immunome Inc. 1.55%
  23. XNCR Xencor Inc. 1.53%
  24. VERA Vera Therapeutics Inc. 1.49%
  25. PVLA Palvella Therapeutics Inc. 1.48%

Sector weights

  • Healthcare 100.00%

Country weights

  • United States 91.87%
  • Canada 2.37%
  • United Kingdom 1.83%
  • China 1.73%
  • Netherlands 1.62%
  • Switzerland 0.33%
  • Belgium 0.25%

Updated 2026-11-04